HUE047126T2 - CD44v6-származék peptidek áttétet képezõ rákok kezelésére - Google Patents

CD44v6-származék peptidek áttétet képezõ rákok kezelésére

Info

Publication number
HUE047126T2
HUE047126T2 HUE13798617A HUE13798617A HUE047126T2 HU E047126 T2 HUE047126 T2 HU E047126T2 HU E13798617 A HUE13798617 A HU E13798617A HU E13798617 A HUE13798617 A HU E13798617A HU E047126 T2 HUE047126 T2 HU E047126T2
Authority
HU
Hungary
Prior art keywords
cd44v6
derived peptides
metastasizing cancers
treating metastasizing
treating
Prior art date
Application number
HUE13798617A
Other languages
English (en)
Hungarian (hu)
Inventor
Veronique Orian-Rousseau
Alexandra Matzke
Helmut Ponta
Original Assignee
Karlsruher Inst Technologie
Amcure Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlsruher Inst Technologie, Amcure Gmbh filed Critical Karlsruher Inst Technologie
Publication of HUE047126T2 publication Critical patent/HUE047126T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE13798617A 2012-11-21 2013-11-21 CD44v6-származék peptidek áttétet képezõ rákok kezelésére HUE047126T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1220889.8A GB201220889D0 (en) 2012-11-21 2012-11-21 CD44v6-derived peptides for treating metastasizing cancers

Publications (1)

Publication Number Publication Date
HUE047126T2 true HUE047126T2 (hu) 2020-04-28

Family

ID=47521460

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13798617A HUE047126T2 (hu) 2012-11-21 2013-11-21 CD44v6-származék peptidek áttétet képezõ rákok kezelésére

Country Status (13)

Country Link
US (1) US9593146B2 (cg-RX-API-DMAC10.html)
EP (1) EP2922563B1 (cg-RX-API-DMAC10.html)
JP (1) JP2016501858A (cg-RX-API-DMAC10.html)
AU (1) AU2013349703B2 (cg-RX-API-DMAC10.html)
CA (1) CA2892147A1 (cg-RX-API-DMAC10.html)
DK (1) DK2922563T3 (cg-RX-API-DMAC10.html)
ES (1) ES2765037T3 (cg-RX-API-DMAC10.html)
GB (1) GB201220889D0 (cg-RX-API-DMAC10.html)
HU (1) HUE047126T2 (cg-RX-API-DMAC10.html)
IL (1) IL238606B (cg-RX-API-DMAC10.html)
LT (1) LT2922563T (cg-RX-API-DMAC10.html)
SI (1) SI2922563T1 (cg-RX-API-DMAC10.html)
WO (1) WO2014079943A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421647D0 (en) * 2014-12-05 2015-01-21 Amcure Gmbh And Ruprecht-Karls-Universitat And Karlsruher Institut F�R Technologie CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases
EP3466963A1 (en) 2017-10-05 2019-04-10 Suigeneris Farmacosmetics, S.L. Anticancer peptides and uses thereof
KR102194025B1 (ko) 2017-12-15 2020-12-22 경북대학교 산학협력단 CD44v6에 결합하는 펩타이드 및 이의 용도
CA3085535A1 (en) 2017-12-22 2019-06-27 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
EP4464714A1 (en) 2023-05-19 2024-11-20 Karlsruher Institut für Technologie Screening method for cell-repelling peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696229A (en) 1995-03-16 1997-12-09 The University Of Virginia Patent Foundation Polypeptide with laminin cell adhesion and morphogenesis activity
DE19540515C1 (de) * 1995-10-31 1997-02-06 Boehringer Ingelheim Int Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten
EP1258255A1 (en) * 2001-05-18 2002-11-20 Boehringer Ingelheim International GmbH Conjugates of an antibody to CD44 and a maytansinoid
JP2003089700A (ja) 2001-09-18 2003-03-28 Life Science Management:Kk ペプチド
EP1417974A1 (en) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapy
WO2005065709A2 (de) * 2003-12-24 2005-07-21 Boehringer Ingelheim International Gmbh Gefriergetrocknete formulierung von antikörperkonjugaten
EP1647556B1 (en) 2004-10-14 2010-05-19 Karlsruher Institut für Technologie Peptidic compounds and derivatives thereof for the treatment of human diseases through inhibition of signaling via growth factors
ATE523204T1 (de) * 2009-02-16 2011-09-15 Karlsruher Inst Technologie Cd44v6-peptide als bakterielle infektionsinhibitoren
EP2266593A1 (en) * 2009-06-24 2010-12-29 Karlsruher Institut für Technologie Use of CD44v6 in the treatment of ophthalmic diseases
WO2011022335A1 (en) * 2009-08-21 2011-02-24 Mount Sinai School Of Medicine Of New York University Methods of using cd44 fusion proteins to treat cancer

Also Published As

Publication number Publication date
EP2922563B1 (en) 2019-10-30
AU2013349703A1 (en) 2015-07-09
ES2765037T3 (es) 2020-06-05
US20150183826A1 (en) 2015-07-02
IL238606B (en) 2019-07-31
US9593146B2 (en) 2017-03-14
AU2013349703B2 (en) 2016-12-22
DK2922563T3 (da) 2020-01-20
CA2892147A1 (en) 2014-05-30
WO2014079943A1 (en) 2014-05-30
SI2922563T1 (sl) 2020-04-30
GB201220889D0 (en) 2013-01-02
EP2922563A1 (en) 2015-09-30
IL238606A0 (en) 2015-06-30
LT2922563T (lt) 2020-03-25
JP2016501858A (ja) 2016-01-21

Similar Documents

Publication Publication Date Title
IL272206A (en) Combined treatment for cancer
IL267242B (en) Cancer treatment
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
SG11201603050TA (en) Methods for treating cancers
IL228644A0 (en) Cancer treatment methods
PL2876447T3 (pl) Sposób wykrywania nowotworu
GB2502503B (en) Luggage apparatus
HRP20160851T1 (hr) Prediktori za liječenje karcinoma
GB201300914D0 (en) Apparatus
IL239031A0 (en) Combined therapy for the treatment of her2-positive cancers
IL238606A0 (en) CD44v6-derivative peptides for the treatment of cancer metastases
SG11201502584XA (en) Peptides and methods for treating cancer
DK2872176T3 (en) Cancer treatment
EP2934500A4 (en) COMBINATION THERAPY AGAINST CANCER
ZA201504169B (en) Anti-adam28 antibody for treating cancer
IL232479A0 (en) Combined treatment of ovarian cancer
GB201220901D0 (en) CD44v6-derived peptides for treating pancreatic cancer
GB201220891D0 (en) CD44v6-derived peptides for treating breast cancers
GB201222563D0 (en) Cancer treatment
EP2854774A4 (en) METHODS OF TREATING INSOMNIA
IL239231A0 (en) Combined cancer treatment
GB201321531D0 (en) Treatment for cancers
GB201118153D0 (en) Therapies for cancers
GB201215167D0 (en) Sanding apparatus
IL228629A0 (en) Cancer detection